Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7480980, 10 pages
https://doi.org/10.1155/2017/7480980
Research Article

A Chinese Herbal Formula, Gengnianchun, Ameliorates β-Amyloid Peptide Toxicity in a Caenorhabditis elegans Model of Alzheimer’s Disease

1Department of Gynecology, The First Hospital of Jilin University, Changchun, China
2Department of Integrated Traditional Chinese Medicine and Western Medicine, Obstetrical and Gynecological Hospital, Fudan University, Shanghai, China

Correspondence should be addressed to Wenjun Wang; moc.361@36gnawnujnew and Yan Fu; nc.ude.ulj@y_f

Received 26 April 2017; Revised 26 August 2017; Accepted 7 September 2017; Published 11 October 2017

Academic Editor: Louise Bennett

Copyright © 2017 Fanhui Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Prince and J. Jackson, “World Alzheimer report,” Tech. Rep., Alzheimer's Disease International, London, UK, 2009. View at Google Scholar
  2. F. Mangialasche, M. Kivipelto, A. Solomon, and L. Fratiglioni, “Dementia prevention: current epidemiological evidence and future perspective,” Alzheimer's Research and Therapy, vol. 4, no. 1, article 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Tabet, “Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!,” Age and Ageing, vol. 35, no. 4, pp. 336–338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. Wenk, G. Quack, H.-J. Moebius, and W. Danysz, “No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use,” Life Sciences, vol. 66, no. 12, pp. 1079–1083, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Li, X. Cui, X. Ma, and Z. Wang, “rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans,” Experimental Gerontology, vol. 89, pp. 78–86, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Xin, R. Yamujala, Y. Wang et al., “Acetylcholineestarase-inhibiting alkaloids from lycoris radiata delay paralysis of amyloid beta-expressing transgenic C. elegans CL4176,” PLoS ONE, vol. 8, no. 5, Article ID e63874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. F. G. Zhao, W. J. Wang, W. J. Zhou, and D. J. Li, “Effect of Gengnianchun Recipe on learning memory function and hippocampal cholinergic system in ovariectomized rats,” Chinese Journal of Integrated Traditional and Western medicine, vol. 28, no. 3, pp. 234–237, 2008. View at Google Scholar · View at Scopus
  8. F. G. Zhao, W. J. Wang, W. J. Zhou, and D. J. Li, “Effect of Gengnianchun formula on hippocampal BDNF of ovariectomized SD rat,” Journal of Experimental Traditional Medical Formulae, vol. 16, no. 15, article 46, 2010. View at Google Scholar
  9. J. Li, W. Wang, D. Li, and W. Zhou, “Gengnianchun recipe inhibits apoptosis of pheochromocytoma cells from beta-amyloid 25-35 insult, better than monotherapies and their compounds,” Neural Regeneration Research, vol. 6, no. 36, pp. 2815–2821, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Li. J., Proteetion of decoction Gengnianehun to PC12 cells and hippocampal cells from Aβ25-35 insult, Fudan University, Shanghai, China, 2010.
  11. S. Kang, Y.-H. Lee, and J. E. Lee, “Metabolism-centric overview of the pathogenesis of Alzheimer’s disease,” Yonsei Medical Journal, vol. 58, no. 3, pp. 479–488, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Luca, A. Luca, and C. Calandra, “The role of oxidative damage in the pathogenesis and progression of Alzheimer's disease and vascular dementia,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 504678, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Meng, J. Li, W. Wang, and Y. Fu, “Gengnianchun, a traditional chinese medicine, enhances oxidative stress resistance and lifespan in caenorhabditis elegans by modulating daf-16/FOXO,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8432306, 10 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Sambamurti, N. H. Greig, and D. K. Lahiri, “Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease,” NeuroMolecular Medicine, vol. 1, no. 1, pp. 1–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Smith, P. L. R. Harris, L. M. Sayre, J. S. Beckman, and G. Perry, “Widespread peroxynitrite-mediated damage in Alzheimer's disease,” The Journal of Neuroscience, vol. 17, no. 8, pp. 2653–2657, 1997. View at Google Scholar · View at Scopus
  17. R. J. Mark, M. A. Lovell, W. R. Markesbery, K. Uchida, and M. P. Mattson, “A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide,” Journal of Neurochemistry, vol. 68, no. 1, pp. 255–264, 1997. View at Google Scholar · View at Scopus
  18. A. Nunomura, G. Perry, M. A. Pappolla et al., “RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease,” The Journal of Neuroscience, vol. 19, no. 6, pp. 1959–1964, 1999. View at Google Scholar · View at Scopus
  19. D. A. Butterfield and D. Boyd-Kimball, “Amyloid β-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain,” Brain Pathology, vol. 14, no. 4, pp. 426–432, 2004. View at Google Scholar · View at Scopus
  20. C. Behl, J. B. Davis, R. Lesley, and D. Schubert, “Hydrogen peroxide mediates amyloid β protein toxicity,” Cell, vol. 77, no. 6, pp. 817–827, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Harris, K. Hensley, D. A. Butterfield, R. A. Leedle, and J. M. Carney, “Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons,” Experimental Neurology, vol. 131, no. 2, pp. 193–202, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhao and B. Zhao, “Oxidative stress and the pathogenesis of Alzheimer's disease,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 316523, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Matsuoka, M. Picciano, J. La Francois, and K. Duff, “Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease,” Neuroscience, vol. 104, no. 3, pp. 609–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Tillement, L. Lecanu, and V. Papadopoulos, “Alzheimer's disease: effects of β-amyloid on mitochondria,” Mitochondrion, vol. 11, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Hansson Petersen, N. Alikhani, H. Behbahani et al., “The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145–13150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Link, “Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9368–9372, 1995. View at Publisher · View at Google Scholar
  27. Y. Wu, Z. Wu, P. Butko et al., “Amyloid-β-induced pathological behaviors are suppressed by Ginkgo biloba extract EGB 761 and ginkgolides in transgenic Caenorhabditis elegans,” The Journal of Neuroscience, vol. 26, no. 50, pp. 13102–13113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J. S. Sangha, X. Sun, O. S. D. Wally et al., “Liuwei dihuang (LWDH), a traditional chinese medicinal formula, protects against β-amyloid toxicity in transgenic Caenorhabditis elegans,” PLoS ONE, vol. 7, no. 8, Article ID e43990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Martorell, E. Bataller, S. Llopis et al., “A cocoa peptide protects Caenorhabditis elegans from oxidative stress and β-amyloid peptide toxicity,” PLoS ONE, vol. 8, no. 5, Article ID e63283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Yang, X. Huang, Q. Wan et al., “Otophylloside B protects against Aβ toxicity in Caenorhabditis elegans models of Alzheimer’s Disease,” Natural Products and Bioprospecting, vol. 7, no. 2, pp. 207–214, 2017. View at Publisher · View at Google Scholar
  31. H. Schägger, “Tricine-SDS-PAGE,” Nature Protocols, vol. 1, no. 1, pp. 16–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. C. Udeochu, J. M. Shea, and S. A. Villeda, “Microglia communication: parallels between aging and Alzheimer's disease,” Clinical and Experimental Neuroimmunology, vol. 7, no. 2, pp. 114–125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Yang, Y. Wei, Q. Xu, and B. Tang, “Progress in epigenetic research on Alzheimer disease,” Chinese Journal of Medical Genetics, vol. 33, no. 2, pp. 252–255, 2016. View at Google Scholar
  34. E. Cohen and A. Dillin, “The insulin paradox: aging, proteotoxicity and neurodegeneration,” Nature Reviews Neuroscience, vol. 9, no. 10, pp. 759–767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Eikelenboom, S.-S. Zhan, W. A. van Gool, and D. Allsop, “Inflammatory mechanisms in Alzheimer's disease,” Trends in Pharmacological Sciences, vol. 15, no. 12, pp. 447–450, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Sekler, J. M. Jiménez, L. Rojo et al., “Cognitive impairment and Alzheimer's disease: links with oxidative stress and cholesterol metabolism,” Neuropsychiatric Disease and Treatment, vol. 4, no. 4, pp. 715–722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Mukhopadhyay, S. W. Oh, and H. A. Tissenbaum, “Worming pathways to and from DAF-16/FOXO,” Experimental Gerontology, vol. 41, no. 10, pp. 928–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Fonte, D. R. Kipp, J. Yerg III et al., “Suppression of in vivo β-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein,” Journal of Biological Chemistry, vol. 283, no. 2, pp. 784–791, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Veerendra Kumar and Y. K. Gupta, “Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 5-6, pp. 336–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. N. H. Turgut, H. Kara, E. Arslanbaş, D. G. Mert, B. Tepe, and H. Güngör, “Effect of Capparis spinosa L. on cognitive impairment induced by D-galactose in mice via inhibition of oxidative stress,” Turkish Journal of Medical Sciences, vol. 45, no. 5, pp. 1127–1136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. C. T. Murphy, S. A. McCarroll, C. I. Bargmann et al., “Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans,” Nature, vol. 424, no. 6946, pp. 277–283, 2003. View at Publisher · View at Google Scholar · View at Scopus